key: cord-0791030-9l9x9zsg
authors: Romero, Jorge; Gabr, Mohamed; Diaz, Juan Carlos; Purkayastha, Sutopa; Gamero, Maria T.; Reynbakh, Olga; Matias, Jose; Alviz, Isabella; Velasco, Alejandro; Della Rocca, Domenico; Moihanty, Sanghamitra; Lin, Aung; Zou, Fengwei; Natale, Andrea; Di Biase, Luigi
title: Electrocardiographic Features of COVID-19 Patients: An Updated Review
date: 2021-10-30
journal: Card Electrophysiol Clin
DOI: 10.1016/j.ccep.2021.10.006
sha: 8fb101cb79ec017fa7b820db88a51fecc95f9a5d
doc_id: 791030
cord_uid: 9l9x9zsg

COVID-19 infection, although primarily a respiratory illness, has numerous manifestations of cardiac involvement including myocardial infarction, myocarditis, and various patterns of changes observed on electrocardiograms. In this review, we discuss the electrocardiographic features that have been described to date in patients affected by this disease, and possible mechanisms contributing to these findings.

Since its declaration as a pandemic more than one year ago, the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected more than 180 million people worldwide and sadly claimed more than 4 million lives, including more than 33 million cases and 600,000 deaths in the United States alone. SARS-CoV-2's effects continue to unravel, as it affects nations worldwide, healthcare systems and economies adjust to battle it, the daily livelihoods of billions of people and patients are touched. In addition, patients, a lot of whom suffer from the aftermaths and morbidity inflicted by the disease, are chronically influenced by SARS-CoV-2. This has led to escalation of efforts by physicians and researchers worldwide for the development of treatments and vaccinations to limit its extension and decrease mortality [1] .

Subsequently, the abundance of data regarding disease processes, disease associations, different manifestations, and pathophysiology of the corona virus infection 2019 has improved our understanding of the disease and how to approach it. Varying mortality rates have been described, ranging from 1 per 100,000 to 100 per 100,000 [2] , and several factors have been associated with higher morbidity and mortality, including previously known comorbidities, advanced age, obesity, or male gender [3] [4] [5] .

Different organ systems are involved as a result of SARS-CoV-2 infection including pulmonary involvement with hypoxemic respiratory failure, which is commonly responsible for deterioration and mortality, renal involvement [6, 7] , multisystem inflammatory syndromes [8] , and a wide array of cardiac manifestations. Numerous studies have described the existence of cardiac involvement in patients infected with SARS-CoV-2, with increased mortality in patients with evidence of cardiac involvement [9] [10] [11] . In addition, cardia involvement has been demonstrated on cardiac imaging such as magnetic resonance imaging (MRI) in patients who recovered from COVID-19 infection [12] , and by evidence of right ventricular J o u r n a l P r e -p r o o f (RV) dysfunction, LV systolic dysfunction, and LV diastolic dysfunction on transthoracic echocardiography [13] . Additionally, cardiac manifestations have been described in electrocardiographic features that include cardiac arrhythmias. ST segment changes, QT prolongation, and arrhythmias.

In this review, we aimed to summarize electrocardiographic characteristics in patients with COVID-19 infection, the pathophysiology behind them, and their implications. We performed a database search of PubMed for articles through July 2021 using the keywords COVID' OR 'coronavirus' OR 'SARS-CoV-2' OR 'SARS' AND 'electrocardiogram' OR'EKG' OR 'ECG' OR "arrhythmia'. The search yielded 1433 results. Prospective and retrospective studies, systematic reviews, meta-analyses, case reports and series, narrative reviews, letters, and clinical guidelines were reviewed. Authors reviewed relevant articles for data to comprehensively discuss and describe the electrocardiographic features encountered thus far in COVID-19 infection. [15] . Conduction abnormalities were also noted in 11.8% of the cohort, with left bundle branch block in 1.5% of the patients, right bundle branch block in 7.8%, and nonspecific intraventricular block in 2.5%. Additionally, 29% of patients had nonspecific repolarization abnormalities. Atrioventricular (AV) block was observed in 2.6%, with the majority (2.5%) being 1 st degree AV block. Atrial premature contractions (APCs) occurred in 7.7% and ventricular premature contractions in 3.4%. Atrial premature contractions, repolarization abnormalities, and right bundle branch block / intraventricular block were predictors of increased mortality [14] . patient symptoms, 50% of these patients underwent coronary angiography, of which 67% were found to have obstructive coronary disease. 44% of the patients described in the cohort were diagnosed with myocardial infarction, while 56% were thought to have non-coronary related myocardial injury [16] . In addition to myocardial infarction, ST segment changes have been attributed to myocardial injury in the form of myocarditis or microthrombi [17] [18] [19] Furthermore, in a recent case series, we described the finding of new T-wave inversion [16] in patients with SARS-CoV-2, and its association with increased mortality and need for intubation and mechanical ventilation, particularly in patients with concomitant elevation of cardiac troponins [21] (figure 2B and C). In this review of 3225 patients admitted with COVID-19

infection, 6% of patients had either new T-wave inversion or pseudonormalization, with 23% of these patients having concomitant troponin elevation. TWI were more notably observed in the lateral leads (71%), anterior leads (64%), inferior leads (57%), and septal leads (26%) leads.

In addition, roughly one quarter of the patients who had a transthoracic echo were found to have regional wall motion abnormalities, and mortality was 35%, 52% and 80% if TWI [15] in patients with evidence of right heart strain [15] . However, in a study of 15 patients with pulmonary embolism and COVID-19, only 1 patient (7%) had the pathognomonic pattern of S1Q3T3 [25] .

QT interval prolongation has been particularly described extensively in patients with COVID-19 infection, due to the potential for arrhythmias or torsades de pointes (TdP) [26] . For instance, in an international multicenter registry that enrolled 110 patients, 14% of patients developed QTc prolongation after 7 days of hospitalization (mean QTc increase 66±20msec, +16%, p<0.001), with a 3.6% incidence of life-threatening arrhythmias [27] . Independent predictors of QTc prolongation included older age, higher basal heart rate, and treatment with dual antiviral therapy. Concurrently, in earlier stages of the pandemic, concerns regarding QTc-J o u r n a l P r e -p r o o f prolonging drugs that were believed to be beneficial for treatment of COVID-19 infection, such as azithromycin, chloroquine, hydroxychloroquine (HCQ), and lopinavir/ritonavir triggered calls for monitoring and caution while using these drugs [28] . are met (QTc ≥ 500 ms or increase in QTc interval ≥ 60 ms) [32] . Additionally, with emerging evidence of lack of benefit of HCQ and azithromycin, administration of these medications, particularly in combination, has been greatly limited.

While Similarly, a meta-analysis of studies that included 5,815 patients with COVID-19 reported an incidence of 9.3% of arrhythmias [34] , and a Heart Rhythm Society survey of electrophysiologists worldwide reported that atrial fibrillation was the most commonly encountered arrhythmia encountered (21%) by professionals treating patients with COVID-19

infection [35] .

Multiple factors likely contribute to arrhythmias in patients affected by COVID-19 infection.

Acute myocardial injury occurring in some patients, can in itself trigger cardiac arrhythmias.

In a study of 1284 patients with severe COVID-19, 170 patients had evidence of myocardial J o u r n a l P r e -p r o o f injury as evidenced by elevated cardiac troponin I, of which 26% had arrhythmias [36] .

Inversely, in a meta-analysis that assessed the role of cardiac injury as a predictor of mortality and severe disease, incidence of new arrhythmias was found to be associated with higher risk of severe disease and the need for ICU admission (RR 13, 95% CI 7.00 to 24.47, P < 0.001) [37] .

Moreover, hypoxia and electrolyte abnormalities may contribute to bradyarrhythmias, atrial fibrillation, and ventricular arrhythmias; and systemic inflammation, viral perimyocarditis, and proarrhythmogenicity induced by certain medications may predispose to atrial and ventricular arrhythmias ( figure 4B ). In addition, bradyarrhythmias, interestingly, have been suggested to be a possible sign associated with developing cytokine storm [38] .

Electrocardiographic 

The battle against COVID-19: mortality in Italy

COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

COVID-19 and Renal Diseases: An Update

Postmortem Kidney Pathology Findings in Patients with COVID-19

Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection -United Kingdom and United States

Cardiology and COVID-19

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation

Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes

The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19

ST-Segment Elevation in Patients with Covid-19 -A Case Series

Myocardial injury and COVID-19: Possible mechanisms

COVID-19 and myocarditis: a systematic review and overview of current challenges

Microthrombi and ST-Segment-Elevation Myocardial Infarction in COVID-19. Circulation

A Systematic Review of COVID-19 and Myocarditis

T-wave inversion as a manifestation of COVID-19 infection: a case series

Surface electrocardiographic characteristics in coronavirus disease 2019: repolarization abnormalities associated with cardiac involvement

The effect of the severity COVID-19 infection on electrocardiography

ECG changes after rabbit coronavirus infection

Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review

QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry

Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

Inpatient Use of Ambulatory Telemetry Monitors for COVID-19

Patients Treated With Hydroxychloroquine and/or Azithromycin

COVID-19 and cardiac arrhythmias

Cardiovascular complications in COVID-19: A systematic review and meta-analysis

COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies

Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury

Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review

COVID-19 infection and cardiac arrhythmias